Drug Enforcement Administration 2005 – Federal Register Recent Federal Regulation Documents

Manufacturer of Controlled Substances Notice of Registration
Document Number: E5-8082
Type: Notice
Date: 2005-12-29
Agency: Drug Enforcement Administration, Department of Justice
Donley D. Siddall, M.D.; Revocation of Registration
Document Number: 05-24497
Type: Notice
Date: 2005-12-28
Agency: Drug Enforcement Administration, Department of Justice
Joey Enterprises, Inc. d/b/a/ NorthStar Wholesale Denial of Application
Document Number: 05-24496
Type: Notice
Date: 2005-12-28
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-7487
Type: Notice
Date: 2005-12-19
Agency: Drug Enforcement Administration, Department of Justice
Implementation of the Anabolic Steroid Control Act of 2004
Document Number: 05-23907
Type: Rule
Date: 2005-12-16
Agency: Drug Enforcement Administration, Department of Justice
The purpose of this rulemaking is to conform the Drug Enforcement Administration's (DEA) regulations to the provisions of the Anabolic Steroid Control Act of 2004. Effective January 20, 2005, the Act amended the Controlled Substances Act (CSA) and replaced the existing definition of ``anabolic steroid'' with a new definition. This new definition altered the basis for all future administrative scheduling actions relating to the control of anabolic steroids as Schedule III controlled substances by eliminating the requirement to prove muscle growth. Additionally, the Act lists 59 specific substances as being anabolic steroids. As such, these substances and their salts, esters and ethers are Schedule III controlled substances. This rulemaking amends 21 CFR Parts 1300 and 1308 to reflect these changes. The Act also amends the CSA by revising the language requiring exclusion of certain over the counter products from regulation as controlled substances. The Act clarifies that the exclusionary language in 21 U.S.C. 811(g)(1) pertains only to non-narcotic ``drugs'' that may, under the Federal Food, Drug, and Cosmetic Act (FDCA), be lawfully sold over the counter without a prescription. The statute is self-implementing with the changes that became effective on January 20, 2005. DEA has no authority to revise the changes and is simply modifying its regulations to conform to the statute. Consequently, public comments are not being solicited since they could not alter this rule.
Controlled Substances: Established Initial Aggregate Production Quotas for 2006
Document Number: E5-7110
Type: Notice
Date: 2005-12-09
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes initial 2006 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Importer of Controlled Substances; Notice of Registration
Document Number: Z5-6606
Type: Notice
Date: 2005-12-05
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-6609
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-6608
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E5-6607
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: E5-6606
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-6605
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-6603
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: E5-6602
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: E5-6592
Type: Notice
Date: 2005-11-29
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances and List I Chemical Registration and Reregistration Application Fees
Document Number: 05-22681
Type: Proposed Rule
Date: 2005-11-16
Agency: Drug Enforcement Administration, Department of Justice
DEA is proposing to adjust the fee schedule for DEA registration and reregistration application fees relating to the registration and control of the manufacture, distribution and dispensing of controlled substances and listed chemicals to appropriately reflect all costs associated with its Diversion Control Program as mandated by 21 U.S.C. 822. Specifically, DEA proposes to revise the fee schedule for controlled substances and List I chemical handlers so that all manufacturers, distributors, importers, exporters, and dispensers of controlled substances and of List I chemicals pay an annual fee, by registrant category, irrespective of whether they handle controlled substances or List I chemicals. This action responds to recent amendments to the Diversion Control Fee Account provisions in the Controlled Substances Act (CSA) and will bring DEA's fee collections into line with the new requirements.
Controlled Substances: Final Revised Aggregate Production Quotas for 2005
Document Number: 05-22287
Type: Notice
Date: 2005-11-09
Agency: Drug Enforcement Administration, Department of Justice
This notice establishes final 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA). The DEA has taken into consideration comments received in response to a notice of the proposed revised aggregate production quotas for 2005 published August 5, 2005 (70 FR 45432).
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: R5-21900
Type: Notice
Date: 2005-11-08
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-21900
Type: Notice
Date: 2005-11-03
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-21896
Type: Notice
Date: 2005-11-03
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-21893
Type: Notice
Date: 2005-11-03
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-21252
Type: Notice
Date: 2005-10-25
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: Proposed Aggregate Production Quotas for 2006
Document Number: 05-21038
Type: Notice
Date: 2005-10-21
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes initial year 2006 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Importer of Controlled Substances; Notice of Registration
Document Number: 05-20950
Type: Notice
Date: 2005-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-20949
Type: Notice
Date: 2005-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-20948
Type: Notice
Date: 2005-10-20
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-19735
Type: Notice
Date: 2005-10-03
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration
Document Number: 05-19192
Type: Notice
Date: 2005-09-27
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-18903
Type: Notice
Date: 2005-09-22
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Embutramide Into Schedule III; Extension of Comment Period
Document Number: 05-17163
Type: Proposed Rule
Date: 2005-08-29
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is extending the comment period and time to request a hearing on the Federal Register Notice of proposed rulemaking entitled ``Schedules of Controlled Substances: Placement of Embutramide into Schedule III'' published on July 29, 2005 (70 FR 43809).
Clarification of Existing Requirements Under the Controlled Substances Act for Prescribing Schedule II Controlled Substances
Document Number: 05-16954
Type: Notice
Date: 2005-08-26
Agency: Drug Enforcement Administration, Department of Justice
On January 18, 2005, DEA published in the Federal Register a solicitation of comments on the subject of dispensing controlled substances for the treatment of pain. Many of the comments that the agency received indicate that there is a need to issue a clarification regarding certain aspects of the prescription requirements for schedule II controlled substances. This document provides such clarification.
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16568
Type: Notice
Date: 2005-08-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-16567
Type: Notice
Date: 2005-08-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16566
Type: Notice
Date: 2005-08-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16565
Type: Notice
Date: 2005-08-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16564
Type: Notice
Date: 2005-08-22
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-16469
Type: Notice
Date: 2005-08-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-16468
Type: Notice
Date: 2005-08-19
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 05-16467
Type: Notice
Date: 2005-08-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16466
Type: Notice
Date: 2005-08-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-16465
Type: Notice
Date: 2005-08-19
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-16288
Type: Notice
Date: 2005-08-17
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 05-15971
Type: Notice
Date: 2005-08-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 05-15970
Type: Notice
Date: 2005-08-12
Agency: Drug Enforcement Administration, Department of Justice
Reports by Registrants of Theft or Significant Loss of Controlled Substances
Document Number: 05-15969
Type: Rule
Date: 2005-08-12
Agency: Drug Enforcement Administration, Department of Justice
DEA is amending its regulations regarding reports by registrants of theft or significant loss of controlled substances. There had been some confusion as to what constitutes a significant loss and when and how initial notice of a theft or loss should be provided to DEA. In this final rule, DEA clarifies the regulations and provides guidance to registrants regarding the theft, significant loss, and unexplained loss of controlled substances.
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-15876
Type: Notice
Date: 2005-08-11
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested:
Document Number: 05-15875
Type: Notice
Date: 2005-08-11
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Proposed Collection; Comments Requested
Document Number: 05-15874
Type: Notice
Date: 2005-08-11
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances: Proposed Revised Aggregate Production Quotas for 2005
Document Number: 05-15493
Type: Notice
Date: 2005-08-05
Agency: Drug Enforcement Administration, Department of Justice
This notice proposes revised 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).
Schedules of Controlled Substances: Placement of Embutramide Into Schedule III
Document Number: 05-15035
Type: Proposed Rule
Date: 2005-07-29
Agency: Drug Enforcement Administration, Department of Justice
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance embutramide, including its salts, into Schedule III of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Acting Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action will impose the regulatory controls and criminal sanctions applicable to Schedule III on those who handle embutramide and products containing embutramide.